Obbligazione Barclay PLC 3.6% ( US06741RBQ39 ) in USD

Emittente Barclay PLC
Prezzo di mercato 100 USD  ⇌ 
Paese  Regno Unito
Codice isin  US06741RBQ39 ( in USD )
Tasso d'interesse 3.6% per anno ( pagato 2 volte l'anno)
Scadenza 17/05/2022 - Obbligazione è scaduto



Prospetto opuscolo dell'obbligazione Barclays PLC US06741RBQ39 in USD 3.6%, scaduta


Importo minimo 1 000 USD
Importo totale 186 000 USD
Cusip 06741RBQ3
Standard & Poor's ( S&P ) rating N/A
Moody's rating N/A
Descrizione dettagliata Barclays PLC è una banca multinazionale britannica che offre una vasta gamma di servizi finanziari a clienti privati, aziende e istituzioni in tutto il mondo.

The Obbligazione issued by Barclay PLC ( United Kingdom ) , in USD, with the ISIN code US06741RBQ39, pays a coupon of 3.6% per year.
The coupons are paid 2 times per year and the Obbligazione maturity is 17/05/2022







http://www.sec.gov/Archives/edgar/data/312070/000110465912037758/...
424B2 1 a12-11047_30424b2.htm 424B2 - BARC_3 60%_RETAIL_10Y

CALCULATION OF REGISTRATION FEE

Title of Each Class of Securities Offered
Maximum Aggregate Offering Price
Amount of Registration Fee(1)






Global Medium-Term Notes, Series A
$186,000
$21.32



(1) Calculated in accordance with Rule 457(r) of the Securities Act of 1933.

1 of 26
5/16/2012 2:55 PM


http://www.sec.gov/Archives/edgar/data/312070/000110465912037758/...

Pricing Supplement dated May 14, 2012
Filed Pursuant to Rule 424(b)(2)
(To Prospectus dated August 31, 2010 and
Registration No. 333-169119
the Prospectus Supplement dated May 27, 2011)



US$186,000

3.60% FIXED RATE NOTES DUE MAY 17, 2022





Principal Amount:
US$186,000
Issuer:
Barclays Bank PLC








Issue Price:
100%
Series:
Global Medium-Term Notes, Series A








Original Issue Date:
May 17, 2012
Return at Maturity:
If you hold the Notes to maturity, you will receive at
least 100% of your principal, subject to the
creditworthiness of Barclays Bank PLC. The Notes
are not, either directly or indirectly, an obligation of
any third party, and any payment to be made on the
Notes, including any principal protection provided at
maturity, depends on the ability of Barclays Bank
PLC to satisfy its obligations as they come due.





Interest Rate Type:
Fixed Rate
Original Trade Date:
May 14, 2012








Maturity Date:
May 17, 2022
CUSIP:
06741RBQ3



ISIN:
US06741RBQ39




Denominations:
Minimum denominations of
Business Day:
x New York
US$1,000 and integral multiples
x London
of US$1,000 thereafter.
o Euro

o Other ( )



Interest Rate:
3.60% per annum



Interest Payment Dates:
o Monthly, o Quarterly, x Semi-Annually, o Annual y,

payable in arrears on the 17
th day of each May and November, commencing on November 17, 2012 and ending on the
Maturity Date or the relevant Survivor's Option Payment Date, if applicable.



Interest Period:
The initial Interest Period wil begin on, and include, the Original Issue Date and end on, but exclude, the first Interest
Payment Date. Each subsequent Interest Period wil begin on, and include, the Interest Payment Date for the
immediately preceding Interest Period and end on, but exclude, the next fol owing Interest Payment Date. The final
Interest Period wil end on, but exclude, the Maturity Date (or the Survivor's Option Payment Date, if applicable).



Survivor's Option:
Upon request by the authorized representative of the beneficial owner of the Notes, we wil repay those Notes prior to
the Maturity Date fol owing the death of the beneficial owner of the Notes, provided such Notes were acquired by the
deceased beneficial owner at least six months prior to the date of the request.

The right to exercise this option wil be subject to:

· limitations on the aggregate dollar amount of exercises by all holders of the Notes offered by this pricing
supplement in any calendar year; and

· a maximum permitted dollar amount of an individual exercise with respect to the Notes offered by this pricing
supplement by a holder of the Notes offered by this pricing supplement in any calendar year.

For additional details regarding the Survivor's Option, see "Risk Factors -- Any Exercise of the Survivor's Option May
Be Limited in Amount and Any Repayments Made With Respect To a Survivor's Option Wil Not Be Made
Immediately" and "Description of Survivor's Option" below.





Business Day Convention:
Fol owing, Unadjusted
Day Count Convention:
30/360






Settlement:
DTC; Book-entry; Transferable.




Listing:
The Notes wil not be listed on any U.S. securities exchange or quotation system.





Price to Public

Agent's Commission

(1)
Proceeds to Barclays Bank PLC






Per Note
100%

1.25%

98.75%
Total
$186,000

$2,325

$183,675

(1)
Barclays Capital Inc. will receive commissions from the Issuer equal to 1.25% of the principal amount of the notes, or $12.50 per $1,000 principal amount, and
may retain all or a portion of these commissions or use all or a portion of these commissions to pay sel ing concessions or fees to other dealers.

The Notes wil not be listed on any U.S. securities exchange or quotation system. Neither the Securities and Exchange Commission nor any state
2 of 26
5/16/2012 2:55 PM


http://www.sec.gov/Archives/edgar/data/312070/000110465912037758/...
securities commission has approved or disapproved of these securities or determined that this pricing supplement is truthful or complete. Any
representation to the contrary is a criminal offense.

We may use this pricing supplement in the initial sale of Notes. In addition, Barclays Capital Inc. or another of our affiliates may use this pricing
supplement in market resale transactions in any Notes after their initial sale. Unless we or our agent informs you otherwise in the confirmation of sale, this
pricing supplement is being used in a market resale transaction.

Any payment on the Notes is subject to the creditworthiness of the Issuer and is not guaranteed by any third party. For a description of risks with
respect to the ability of Barclays Bank PLC to satisfy its obligations as they come due, see "Issuer Credit Risk" in this pricing supplement.

Investing in the Notes involves a number of risks. See "Risk Factors" beginning on page S-6 of the prospectus supplement and "Selected
Risk Factors" below.

3 of 26
5/16/2012 2:55 PM


http://www.sec.gov/Archives/edgar/data/312070/000110465912037758/...


The Notes constitute our direct, unconditional, unsecured and unsubordinated obligations and are not deposit
liabilities of Barclays Bank PLC and are not insured by the U.S. Federal Deposit Insurance Corporation or any
other governmental agency of the United States, the United Kingdom or any other jurisdiction.

We urge you to consult your investment, legal, tax, accounting and other advisers and to invest in the Notes
only after you and your advisors have carefully considered the suitability of an investment in the Notes in light
of your particular circumstances.

Barclays Bank PLC has filed a registration statement (including a prospectus) with the SEC for the offering to
which this pricing supplement relates. Before you invest, you should read the prospectus dated August 31,
2010, the prospectus supplement dated May 27, 2011, and other documents Barclays Bank PLC has filed with
the SEC for more complete information about Barclays Bank PLC. and this offering. Buyers should rely upon
this pricing supplement, the prospectus, the prospectus supplement, and any relevant free writing prospectus
for complete details. You may get these documents and other documents Barclays Bank PLC has filed for free
by visiting EDGAR on the SEC website at www.sec.gov, and you may also access the prospectus and
prospectus supplement through the links below:

·
Prospectus dated August 31, 2010:


http://www.sec.gov/Archives/edgar/data/312070/000119312510201448/df3asr.htm

·
Prospectus Supplement dated May 27, 2011:


http://www.sec.gov/Archives/edgar/data/312070/000119312511152766/d424b3.htm

Our Central Index Key, or CIK, on the SEC website is 0000312070.

Alternatively, Barclays Capital Inc. or any agent or dealer participating in this offering will arrange to send you
this pricing supplement, the prospectus, the prospectus supplement and any relevant free writing prospectus if
you request it by calling your Barclays Capital Inc. sales representative, such dealer or 1-888-227-2275
(Extension 2-3430). A copy of the prospectus may be obtained from Barclays Capital Inc., 745 Seventh Avenue
--Attn: US InvSol Support, New York, NY 10019.

We reserve the right to change the terms of, or reject any offer to purchase the Notes prior to their issuance. In the
event of any changes to the terms of the Notes, we wil notify you and you wil be asked to accept such changes in
connection with your purchase. You may also choose to reject such changes in which case we may reject your offer to
purchase.

As used in this term sheet, the "Company," "we," "us," or "our" refers to Barclays Bank PLC.

4 of 26
5/16/2012 2:55 PM


http://www.sec.gov/Archives/edgar/data/312070/000110465912037758/...

SELECTED RISK FACTORS

An investment in the Notes involves significant risks. You should read the risks summarized below in
connection with, and the risks summarized below are qualified by reference to, the risks described in more
detail in the "Risk Factors" section beginning on page S-6 of the prospectus supplement. We urge you to
consult your investment, legal, tax, accounting and other advisers and to invest in the Notes only after you and
your advisors have carefully considered the suitability of an investment in the Notes in light of your particular
circumstances.

·
Issuer Credit Risk-- The Notes are our unsecured debt obligations, and are not, either directly or indirectly, an

obligation of any third party. Any payment to be made on the Notes, including any principal protection provided
at maturity, depends on our ability to satisfy our obligations as they come due. As a result, the actual and
perceived creditworthiness of Barclays Bank PLC may affect the market value of the Notes and, in the event we
were to default on our obligations, you may not receive the principal protection or any other amounts owed to
you under the terms of the Notes.

·
Certain Built-In Costs Are Likely to Adversely Affect the Value of the Notes Prior to Maturity--While the

payment at maturity described in this pricing supplement is based on the ful principal amount of your Notes, the
original issue price of the Notes includes the agent's commission and the cost of hedging our obligations under
the Notes through one or more of our affiliates. As a result, the price, if any, at which Barclays Capital Inc. and
other affiliates of Barclays Bank PLC wil be wil ing to purchase Notes from you in secondary market
transactions wil likely be lower than the price you paid for your Notes, and any sale prior to the Maturity Date
could result in a substantial loss to you.

·
Potential Conflicts--We and our affiliates play a variety of roles in connection with the issuance of the Notes,

including hedging our obligations under the Notes. In performing these duties, the economic interests of our
affiliates of ours are potentially adverse to your interests as an investor in the Notes.

In addition, Barclays Wealth, the wealth management division of Barclays Capital Inc., may arrange for the sale
of the Notes to certain of its clients. In doing so, Barclays Wealth wil be acting as agent for Barclays Bank PLC
and may receive compensation from Barclays Bank PLC in the form of discounts and commissions. The role of
Barclays Wealth as a provider of certain services to such customers and as agent for Barclays Bank PLC in
connection with the distribution of the Notes to investors may create a potential conflict of interest, which may be
adverse to such clients. Barclays Wealth is not acting as your agent or investment adviser, and is not
representing you in any capacity with respect to any purchase of Notes by you. Barclays Wealth is acting solely
as agent for Barclays Bank PLC. If you are considering whether to invest in the Notes through Barclays Wealth,
we strongly urge you to seek independent financial and investment advice to assess the merits of such
investment.

·
Lack of Liquidity--The Notes wil not be listed on any securities exchange. Barclays Capital Inc. and other

affiliates of Barclays Bank PLC intend to make a secondary market for the Notes but are not required to do so,
and may discontinue any such secondary market making at any time, without notice. Barclays Capital Inc. may
at any time hold unsold inventory, which may inhibit the development of a secondary market for the Notes. Even
if there is a secondary market, it may not provide enough liquidity to al ow you to trade or sel the Notes easily.
Because other dealers are not likely to make a secondary market for the Notes, the price at which you may be
able to trade your Notes is likely to depend on the price, if any, at which Barclays Capital Inc. and other affiliates
of Barclays Bank PLC are wil ing to buy the Notes. The Notes are not designed to be short-term trading
instruments. Accordingly, you should be able and wil ing to hold your Notes to maturity.

·
Any Exercise of the Survivor's Option May Be Limited in Amount and Any Repayments Made With

Respect to a Survivor's Option Will Not Be Made Immediately -- The Survivor's Option is a provision of the
Notes pursuant to which we agree to repay the Notes, if requested by an authorized representative of the
beneficial owner of the Notes, fol owing the death of the beneficial owner of the Notes, provided that the Notes
were acquired by the beneficial owner at least six months prior to the date of the request. Acceptance of an
exercise of a Survivor's Option and determinations regarding the eligibility and validity of any exercise of a
Survivor's Option wil be at our sole discretion. We also have the discretionary right to apply a limit set to the
aggregate principal amount of Notes as to which exercises of the Survivor's Option wil be accepted by us from
5 of 26
5/16/2012 2:55 PM


http://www.sec.gov/Archives/edgar/data/312070/000110465912037758/...
all authorized representatives of deceased beneficial owners of Notes offered by this pricing supplement in any
calendar year to an amount equal to 2% of the aggregate principal amount of Notes offered by this pricing

PS-1
6 of 26
5/16/2012 2:55 PM


http://www.sec.gov/Archives/edgar/data/312070/000110465912037758/...

supplement outstanding as of the end of the most recent calendar year. In addition, we have the discretionary
right to limit to $250,000 the aggregate principal amount of Notes offered by this pricing supplement as to which
exercises of the Survivor's Option wil be accepted by us from the authorized representative of any deceased
beneficial owner of the Notes offered by this pricing supplement in any calendar year. Accordingly, no assurance
can be given that the valid exercise of a Survivor's Option, if any, for a desired amount wil be permitted in any
single calendar year. In addition, as a result of the foregoing limitations, in some cases exercises of a Survivor's
Option may not result in any payment in the year that the Survivor's Option has been exercised, or in one or
more years subsequent to the year that the Survivor's Option was first exercised. Furthermore, Survivor's
Option claims that were subject to the foregoing limitations in one or more preceding year wil be deemed to be
tendered in a succeeding calendar year (subject to the satisfaction of the conditions specified below, including
the submission of a Survivor's Option Reaffirmation Form (as defined below)) and in such succeeding calendar
year wil again be subject to the limitations described above. As a result, additional Survivor's Option exercises
made in any such succeeding calendar year are more likely to be limited by the limitations described above
because the resubmission of the Survivor's Option exercises that were subject to the limitations in preceding
years may result in the limitation thresholds described above being reached earlier in succeeding calendar
years. These limitations and our discretion in applying any such limitations are discussed in more detail under
the "Description of the Survivor's Option" below.

If a valid request to exercise the Survivor's Option is not ful y accepted in any calendar year due to the
application of any of the limitations described in the preceding paragraph and in "Description of the Survivor's
Option" below, the Notes wil be deemed to be tendered in the fol owing calendar year only if an authorized
representative of the deceased beneficial owner and any Financial Institution (as defined below) through which
the beneficial ownership interest in the Notes is held by the deceased beneficial owner reaffirms the exercise of
the Survivor's Option by submitting a Survivor's Option Reaffirmation Form (as defined below). If a completed
Survivor's Option Reaffirmation Form is not submitted to the trustee within 10 business days fol owing the
delivery thereof by the trustee to the relevant Financial Institution through which the beneficial ownership interest
in the Notes is held by the deceased beneficial owner, the election to exercise the Survivor's Option wil be
deemed to have been withdrawn. The requirements relating to Survivor's Option Reaffirmation Forms are
described in more detail under the heading "Description of the Survivor's Option" below.

In addition, even if the Notes accepted for repayment pursuant to the valid exercise of a Survivor's Option in a
certain calendar year, you wil not receive immediate repayment. Repayment on Notes so accepted wil only be
made on the first of two Survivor's Option Payment Dates (either May 15 or November 15) that occurs 30 or
more calendar days after the date of acceptance.

Whether you should exercise a Survivor's Option if you meet the eligibility requirements to do so is a decision
you wil need to make in consultation with your investment, legal, accounting, tax and other advisers, after
considering al the facts and circumstances of your situation. An additional consideration that you may wish to
take into account is the prevailing secondary market prices for the notes, if any, at the time you are considering
the exercise of the Survivor's Option or the submission of a Survivor's Option Reaffirmation Form. In some
circumstances, such secondary market prices, if any, may be greater than the price you would receive upon the
exercise of your Survivor's Option. Accordingly, you should contact your advisers to determine the prevailing
secondary market prices of the Notes, if any, in order to determine whether to sel the notes to a market
participant at such secondary market prices, if any, or to exercise the Survivor's Option to receive repayment at
a price equal to 100% of the principal amount plus accrued and unpaid interest.

For additional details regarding the Survivor's Option, see "Description of the Survivor's Option" in this pricing
supplement.

·
Many Economic and Market Factors Will Impact the Value of the Notes--The value of the Notes wil be

affected by a number of economic and market factors that may either offset or magnify each other, including:

o the time to maturity of the Notes;
o interest and yield rates in the market general y;
o a variety of economic, financial, political, regulatory or judicial events; and
o our creditworthiness, including actual or anticipated downgrades in our credit ratings.

7 of 26
5/16/2012 2:55 PM


http://www.sec.gov/Archives/edgar/data/312070/000110465912037758/...
PS-2
8 of 26
5/16/2012 2:55 PM


http://www.sec.gov/Archives/edgar/data/312070/000110465912037758/...

DESCRIPTION OF SURVIVOR'S OPTION

Upon request by the authorized representative of the beneficial owner of the Notes, Barclays Bank PLC wil repay those
Notes prior to the Maturity Date fol owing the death of the beneficial owner of the Notes (the ``Survivor's Option''),
provided such Notes were acquired by the deceased beneficial owner at least six months prior to the date of the
request. Upon the valid exercise of the Survivor's Option and the proper tender of the Notes for repayment, Barclays
Bank PLC, subject to the limitations described below, wil repay such Notes, in whole or in part, at a price equal to 100%
of the principal amount of the deceased beneficial owner's beneficial interest in the Notes plus accrued and unpaid
interest to the date of repayment. For purposes of this section, a beneficial owner of Notes is a person who has the
right, immediately prior to such person's death, to receive the proceeds from the disposition of such Notes, as wel as
the right to receive payment of the principal of the Notes.

To be valid, the Survivor's Option must be exercised by or on behalf of the person who has authority to act on behalf of
the deceased beneficial owner of the Notes under the laws of the applicable jurisdiction (including, without limitation, the
personal representative of or the executor of the estate of the deceased beneficial owner or the surviving joint owner
with the deceased beneficial owner) (for purposes of this section, the authorized representative of a deceased beneficial
owner shal be referred to as an "Authorized Representative").

The death of a person holding a beneficial ownership interest in the Notes: (1) with any person in a joint tenancy with
right of survivorship; or (2) with his or her spouse in tenancy by the entirety, tenancy in common, as community property
or in any other joint ownership arrangement, wil be deemed the death of a beneficial owner of those Notes, and the
entire principal amount of the Notes (subject to the limitations described below) held in this manner wil be subject to
repayment by Barclays Bank PLC upon request. However, the death of a person holding a beneficial ownership interest
in Notes as tenant in common with a person other than his or her spouse wil be deemed the death of a beneficial owner
only with respect to such deceased person's interest in the Notes, and only the deceased beneficial owner's percentage
interest in the principal amount of the Notes wil be subject to repayment.

If the ownership interest in the Notes is held by a nominee for a beneficial owner or by a custodian under a Uniform Gifts
to Minors Act or Uniform Transfer to Minors Act, or by a trustee of a trust, or by a guardian or committee for a beneficial
owner, the death of the beneficial owner of the Notes wil constitute death of the beneficial owner for purposes of the
Survivor's Option, if the beneficial ownership interest can be established to the satisfaction of Barclays Bank PLC. In
these cases, the death of the nominee, custodian, trustee, guardian or committee wil not be deemed the death of the
beneficial owner of the Notes for purposes of the Survivor's Option.

Notes beneficially owned by a trust wil be regarded as beneficially owned by each beneficiary of the trust to the extent
of that beneficiary's interest in the trust (however, a trust's beneficiaries col ectively cannot be beneficial owners of more
Notes than are owned by the trust); provided that the beneficiary has a current interest in the trust, which may be
evidenced by a current right to receive distributions or other proceeds from the trust. The death of a beneficiary of a
trust wil be deemed the death of the beneficial owner of the Notes beneficial y owned by the trust to the extent of that
beneficiary's interest in the trust; however, only the death of al such individuals who are tenants by the entirety or joint
tenants in a tenancy which is the beneficiary of a trust wil be deemed the death of the beneficiary of the trust. The death
of an individual who was a tenant in common in a tenancy which is the beneficiary of a trust wil be deemed the death of
the beneficiary of the trust only with respect to the deceased holder's beneficial ownership interest in the Notes, unless
spouses are the tenants in common, in which case only the death of both spouses wil be deemed the death of the
beneficiary of the trust.

Barclays Bank PLC has the discretionary right to limit the aggregate principal amount of the Notes as to which exercises
of the Survivor's Option wil be accepted by it from all authorized representatives of deceased beneficial owners of
Notes offered by this pricing supplement in any calendar year, to an amount equal to 2.0% of the aggregate amount of
the Notes offered by this pricing supplement, outstanding as of the end of the most recent calendar year ("Aggregate
Put Limitation").

Barclays Bank PLC also has the discretionary right to limit to $250,000 the aggregate principal amount of Notes offered
pursuant to this pricing supplement as to which exercises of the Survivor's Option wil be accepted by Barclays Bank
PLC from the Authorized Representative for any individual deceased beneficial owner of such Notes in any calendar year
("Individual Put Limitation", and together with the "Aggregate Put Limitation", the "Put Limitations").

In addition, the exercise of the Survivor's Option (a) for a principal amount of less than $1,000 or (b) if such exercise
would result in a Note with a principal amount of less than $1,000 outstanding, wil not be permitted. If, however, the
original principal amount of such Notes was less than $1,000, the Authorized Representative may exercise the Survivor's
9 of 26
5/16/2012 2:55 PM


http://www.sec.gov/Archives/edgar/data/312070/000110465912037758/...
Option, but only for the ful principal amount of such Note.

PS-3
10 of 26
5/16/2012 2:55 PM